diphenylamine and alovudine
diphenylamine has been researched along with alovudine in 2 studies
Research
Studies (2)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Aboagye, EO; Aigbirhio, FI; Golovko, O; He, Q; Lees, M; Leyton, J; Nguyen, QD; Perumal, M; Smith, G; Workman, P | 1 |
Haagensen, EJ; Harnor, SJ; Maxwell, RJ; Newell, DR; Payne, SL; Rennison, T; Smith, KM; Thomas, HD; Wilson, I | 1 |
Other Studies
2 other study(ies) available for diphenylamine and alovudine
Article | Year |
---|---|
Noninvasive imaging of cell proliferation following mitogenic extracellular kinase inhibition by PD0325901.
Topics: Animals; Benzamides; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Dideoxynucleosides; Diphenylamine; Fluorescent Antibody Technique; Gene Expression Regulation, Neoplastic; Humans; Ki-67 Antigen; MAP Kinase Kinase 1; Mice; Mice, Inbred BALB C; Phosphorylation; Positron-Emission Tomography; RNA, Messenger; Thymidine Kinase; Xenograft Model Antitumor Assays | 2008 |
The enhanced in vivo activity of the combination of a MEK and a PI3K inhibitor correlates with [18F]-FLT PET in human colorectal cancer xenograft tumour-bearing mice.
Topics: Animals; Antiviral Agents; Benzamides; Cell Line, Tumor; Colorectal Neoplasms; Dideoxynucleosides; Diphenylamine; Drug Synergism; Female; Heterografts; Humans; Indazoles; MAP Kinase Kinase Kinases; Mice; Mice, Nude; Neoplasm Transplantation; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Positron-Emission Tomography; Proto-Oncogene Proteins c-akt; Radiography; Sulfonamides | 2013 |